Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherClinical Investigations (Human)

First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography

Simone Krebs, Darren R Veach, Lukas M Carter, Milan Grkovski, Monica Fornier, Michael J Mauro, Martin H Voss, Daniel C Danila, Eva Burnazi, Manda Null, Kevin Staton, Christina Pressl, Bradley Jay Beattie, Pat B. Zanzonico, Wolfgang Andreas Weber, Serge K. Lyashchenko, Jason S. Lewis, Steven M. Larson and Mark P.S. Dunphy
Journal of Nuclear Medicine March 2020, jnumed.119.234864; DOI: https://doi.org/10.2967/jnumed.119.234864
Simone Krebs
1 Memorial Sloan Kettering Cancer Center, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Darren R Veach
1 Memorial Sloan Kettering Cancer Center, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lukas M Carter
1 Memorial Sloan Kettering Cancer Center, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Milan Grkovski
1 Memorial Sloan Kettering Cancer Center, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Monica Fornier
1 Memorial Sloan Kettering Cancer Center, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J Mauro
1 Memorial Sloan Kettering Cancer Center, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin H Voss
1 Memorial Sloan Kettering Cancer Center, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel C Danila
1 Memorial Sloan Kettering Cancer Center, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eva Burnazi
1 Memorial Sloan Kettering Cancer Center, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manda Null
1 Memorial Sloan Kettering Cancer Center, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin Staton
1 Memorial Sloan Kettering Cancer Center, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina Pressl
2 The Rockefeller University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bradley Jay Beattie
1 Memorial Sloan Kettering Cancer Center, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pat B. Zanzonico
3 Memorial Sloan-Kettering Cancer Center;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Andreas Weber
4 Technical University of Munich
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Serge K. Lyashchenko
1 Memorial Sloan Kettering Cancer Center, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason S. Lewis
3 Memorial Sloan-Kettering Cancer Center;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven M. Larson
3 Memorial Sloan-Kettering Cancer Center;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark P.S. Dunphy
1 Memorial Sloan Kettering Cancer Center, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

jnumed.119.234864
DOI 
https://doi.org/10.2967/jnumed.119.234864
PubMed 
32169913

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online March 13, 2020.

Article Versions

  • You are currently viewing a previous version of this article (March 13, 2020 - 14:12).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2020 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Simone Krebs1,
  2. Darren R Veach1,
  3. Lukas M Carter1,
  4. Milan Grkovski1,
  5. Monica Fornier1,
  6. Michael J Mauro1,
  7. Martin H Voss1,
  8. Daniel C Danila1,
  9. Eva Burnazi1,
  10. Manda Null1,
  11. Kevin Staton1,
  12. Christina Pressl2,
  13. Bradley Jay Beattie1,
  14. Pat B. Zanzonico3,
  15. Wolfgang Andreas Weber4,
  16. Serge K. Lyashchenko1,
  17. Jason S. Lewis3,
  18. Steven M. Larson3 and
  19. Mark P.S. Dunphy1
  1. 1 Memorial Sloan Kettering Cancer Center, United States;
  2. 2 The Rockefeller University;
  3. 3 Memorial Sloan-Kettering Cancer Center;
  4. 4 Technical University of Munich
  1. For correspondence or reprints contact: Mark P.S. Dunphy, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States. E-mail: dunphym@mskcc.org

Statistics from Altmetric.com

Cited By...

  • 5 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Insight into the Development of PET Radiopharmaceuticals for Oncology
    Joseph Lau, Etienne Rousseau, Daniel Kwon, Kuo-Shyan Lin, François Bénard, Xiaoyuan Chen
    Cancers 2020 12 5
  • The promise of metabolic imaging in diffuse midline glioma
    Samantha Lovibond, Alexandra N. Gewirtz, Luca Pasquini, Simone Krebs, Maya S. Graham
    Neoplasia 2023 39
  • The Unique Pharmacometrics of Small Molecule Therapeutic Drug Tracer Imaging for Clinical Oncology
    Mark P. S. Dunphy, Nagavarakishore Pillarsetty
    Cancers 2020 12 9
  • Detection of Experimental Colorectal Peritoneal Metastases by a Novel PDGFRβ-Targeting Nanobody
    Esther Strating, Sjoerd Elias, Guus van Scharrenburg, Kaisa Luoto, André Verheem, Inne Borel Rinkes, Herman Steen, Onno Kranenburg
    Cancers 2022 14 18
  • Mini-review: Antibody-PET of receptor tyrosine kinase interplay and heterogeneity
    Anusha Chegu, Sandeep Surendra Panikar, Patricia M.R. Pereira
    Nuclear Medicine and Biology 2022 108-109

Article usage

Article usage: March 2020 to April 2025

AbstractFullPdf
Mar 2020489048
Apr 2020207016
May 202012206
Jun 20207608
Jul 20205304
Aug 202010506
Sep 202084045
Oct 202092017
Nov 202012362683
Dec 2020245816
Jan 20211911116
Feb 20212021613
Mar 202113976
Apr 20211831312
May 2021485523
Jun 2021333519
Jul 2021256228
Aug 2021193318
Sep 2021186025
Oct 2021185340
Nov 2021143628
Dec 2021334536
Jan 2022224018
Feb 2022212616
Mar 2022113319
Apr 2022193113
May 2022103520
Jun 202262112
Jul 20227337
Aug 2022113220
Sep 2022242514
Oct 2022181616
Nov 2022113813
Dec 2022153012
Jan 20233359
Feb 2023123512
Mar 202373214
Apr 202310259
May 202341610
Jun 202372516
Jul 202383321
Aug 2023111815
Sep 2023173842
Oct 202382712
Nov 202353321
Dec 20239509
Jan 2024213415
Feb 20249317
Mar 2024122023
Apr 2024410818
May 2024134616
Jun 2024114717
Jul 2024133523
Aug 2024304518
Sep 202493425
Oct 202493516
Nov 202494118
Dec 202483518
Jan 202574026
Feb 2025912330
Mar 2025108137
Apr 2025136441
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 66 (5)
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography
Simone Krebs, Darren R Veach, Lukas M Carter, Milan Grkovski, Monica Fornier, Michael J Mauro, Martin H Voss, Daniel C Danila, Eva Burnazi, Manda Null, Kevin Staton, Christina Pressl, Bradley Jay Beattie, Pat B. Zanzonico, Wolfgang Andreas Weber, Serge K. Lyashchenko, Jason S. Lewis, Steven M. Larson, Mark P.S. Dunphy
Journal of Nuclear Medicine Mar 2020, jnumed.119.234864; DOI: 10.2967/jnumed.119.234864

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography
Simone Krebs, Darren R Veach, Lukas M Carter, Milan Grkovski, Monica Fornier, Michael J Mauro, Martin H Voss, Daniel C Danila, Eva Burnazi, Manda Null, Kevin Staton, Christina Pressl, Bradley Jay Beattie, Pat B. Zanzonico, Wolfgang Andreas Weber, Serge K. Lyashchenko, Jason S. Lewis, Steven M. Larson, Mark P.S. Dunphy
Journal of Nuclear Medicine Mar 2020, jnumed.119.234864; DOI: 10.2967/jnumed.119.234864
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The added value of 18F-FDG PET/CT compared to 68Ga-PSMA PET/CT in patients with castration-resistant prostate cancer
Show more Clinical Investigations (Human)

Similar Articles

Keywords

  • Molecular imaging
  • Oncology: General
  • radiopharmaceuticals
  • 18F-SKI-249380
  • Dasatinib
  • PET imaging
  • Src kinase
SNMMI

© 2025 SNMMI

Powered by HighWire